Offer Request Form

Order list is empty

Shikari® (S-ATOCR) Anti-Ocrelizumab ELISA w/confirmation

Enzyme immunoassay for the quantitative determination of antibodies to of Ocrelizumab (Ocrevus®) in serum and plasma with confirmation.

This kit has been especially developed for the quantitative antibodies to Ocrelizumab in serum and plasma samples

This kit can be efficiently used for monitoring anti- ocrelizumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-ocrelizumab antibodies.

All SHIKARI® ELISA kits are suitable for biosimilar work.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact techsupport@matriksbiotek.com

Required Volume (µl) 20
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 7,5
Spike Recovery (%) Between 85-115
Shelf Life (year) 1
Assay type Quantitative
Species Reactivity Human
Storage conditions Store at +4°C. Please refer to protocols.
Shipping conditions At room temperature
# File Action
Validation Report Download
Instructions For Use Download
SDS Download

Publications with this drug

# File Action